Pfizer Appeals China's Decision To Overturn Viagra Patent
Pfizer Inc. will file an official appeal Tuesday against a decision by China's State Intellectual Property Office to overturn the U.S. drug maker's patent for erectile-dysfunction drug Viagra, the Wall Street...To view the full article, register now.
Already a subscriber? Click here to view full article